Why Didn't Anyone Catch the Flu in This Experiment?


What happens when you lock healthy people in a room with flu-infected individuals for hours, and nobody gets sick?

Welcome to FreeAstroScience.com, where we break down complex scientific principles into simple terms. We're thrilled you've joined us today. If you've ever wondered why some people catch the flu easily while others seem immune, you're in the right place. A fascinating new study just flipped our assumptions about influenza transmission upside down. Stick with us until the end—we promise you'll walk away seeing the common flu in a whole new light.


The Surprising Result Nobody Expected

Let's set the scene. Researchers at the University of Maryland designed one of the most ambitious flu transmission experiments ever attempted. They recruited people who'd naturally caught influenza—not through lab inoculation but through real-world exposure. Then they placed these sick individuals in hotel rooms with healthy volunteers.

For hours. Day after day. With sealed doors and windows.

The result? Not a single healthy person caught the flu.

We know what you're thinking: How is that even possible? After all, we've been told our whole lives that being near someone with the flu means we'll probably catch it too. This study, published in PLOS Pathogens in January 2026, tells a different story.


What Did the Experiment Involve?

The EMIT-2 study (Evaluating Modes of Influenza Transmission) ran four quarantine cohorts between 2023 and 2024. Let's break down what actually happened inside that Baltimore hotel.

The Participants

The research team assembled two groups:

Donors: Five naturally infected individuals with confirmed influenza (mean age: 21 years, 80% female). Three had H3N2 infections, and two had H1N1.

Recipients: Eleven healthy volunteers (mean age: 36 years, 54% female) who agreed to spend two weeks in quarantine.

EMIT-2 Study Participant Demographics
Characteristic Donors (n=5) Recipients (n=11)
Mean Age 21 years 36 years
Female (%) 80% 54%
Vaccinated This Season 40% 18%
Virus Types H3N2 (3), H1N1 (2) N/A

The Exposure Setup

The conditions were deliberately designed to favor viral spread:

  • Temperature: 22–25°C (ideal for participant comfort and virus survival)
  • Humidity: 20–45% (low humidity helps influenza viruses thrive)
  • Ventilation: Very low, around 0.25–0.5 air changes per hour
  • Duration: 23 exposure events totaling 82.2 hours of contact

During these sessions, participants weren't just sitting quietly. They played card games like UNO. They danced. They practiced yoga. They passed markers, tablets, and microphones from hand to hand. The activities were chosen to maximize both airborne and surface contact exposure.


Why Did Zero People Get Infected?

Here's where things get interesting. Despite all those hours of close contact, shared objects, and sealed rooms, the researchers found:

  • Zero PCR-positive respiratory samples from recipients
  • Zero flu-like symptoms in recipients
  • Zero serological evidence of infection

The scientists didn't just scratch their heads and give up. They dug deep into the data and identified three main explanations.

Explanation 1: The Donors Weren't Shedding Much Virus

This might be the biggest surprise. We often assume that anyone with the flu is a walking virus factory. But the data showed something different.

Among 16 exhaled breath samples from donors:

  • Only 44% contained detectable viral RNA in fine aerosols
  • Just 6% contained culturable (infectious) virus
  • Viral RNA copies ranged from 79 to 8,900 per 30-minute sample

Compare this to previous studies of community-acquired flu cases, where shedding rates ranged from 38% to 86%. The EMIT-2 donors were on the low end.

Explanation 2: The Recipients Had Hidden Protection

Most of the healthy volunteers had low hemagglutination inhibition (HAI) titers—the standard measure of flu antibodies. In theory, they should've been vulnerable. But the ELISA tests told a different story.

Recipients showed higher binding antibody responses than donors at baseline. Years of exposure to various flu strains and vaccinations had given their immune systems a head start. The middle-aged recipients (average age 36) had accumulated more cross-reactive immunity than the younger donors (average age 21).

Explanation 3: The Air Was Too Well-Mixed

This explanation surprised even the researchers. To control temperature and humidity in a sealed room with multiple occupants, they ran two fan coil units and two large dehumidifiers at high speed.

The unintended consequence? Rapid air mixing diluted and dispersed the viral clouds before recipients could inhale concentrated doses.

Think of it like this: if someone exhales virus-laden breath, that cloud is most dangerous in the first few seconds when it's concentrated. Rapid air circulation breaks up these plumes almost immediately. Instead of breathing in a dense viral fog, recipients were exposed to widely dispersed, diluted particles.


Does Coughing Really Matter That Much?

Short answer: Yes. A lot more than we thought.

The EMIT-2 donors rarely coughed. During 30-minute breath collection periods, cough counts ranged from 0 to 16, with a median of zero. Sneeze counts? Zero to one, median zero.

The only donor whose breath sample showed infectious virus (147 focus-forming units) was also the one who coughed the most during sample collection—six times in 30 minutes. And this was on their last day in quarantine.

This aligns with previous research showing that cough observed during sample collection is a major predictor of viral aerosol shedding. The study authors put it bluntly:

"For future controlled studies of transmission from natural infections, it may be necessary to focus on recruiting donors who cough."

The Superspreader Connection

Not everyone with the flu spreads it equally. Previous studies show enormous variation in how much virus individuals release:

  • Some people shed 100 to 1,000 times more virus than average
  • Geometric mean shedding rates suggest only symptomatic cases with cough would reliably shed infectious doses
  • Mild cases might rarely be contagious at all

This heterogeneity helps explain the "superspreader" phenomenon we saw during COVID-19. It's not just about exposure time—it's about who you're exposed to and what they're doing.


How Does Pre-Existing Immunity Protect Us?

We need to talk about age for a moment. The study's recipients were notably older than its donors—15 years older on average. This age gap turned out to be more significant than anyone expected.

Why Age Matters

Older adults have had more time to:

  • Encounter different flu strains through natural infection
  • Receive multiple flu vaccinations
  • Build up cross-reactive antibodies that recognize various influenza variants

The researchers noted that middle-aged adults are less likely than young adults to show evidence of infection in population studies. Their immune systems have essentially been "training" for decades.

Estimated Infectious Dose Formula

Infectious Quantum ≈ 1.4 × 105 RNA copies

Based on EMIT-1 transmission data and aerosol inoculation experiments

What the Recipients Actually Received

Using air sampling data and breathing rate estimates, the researchers calculated actual viral exposures:

  • Cohort 24b recipients: approximately 750 RNA copies each
  • Cohort 24c recipients: approximately 290 RNA copies each

These numbers fall well below the estimated infectious dose of 104 to 105 RNA copies. The combination of low donor shedding and diluted air meant recipients never received enough virus to establish infection.


Can Air Circulation Stop the Flu?

This is where the study gets really practical. The room had low fresh air ventilation—just 0.25 to 0.5 air changes per hour. That sounds bad for preventing infection, right?

But the fan coil units and dehumidifiers created intense air recirculation within the sealed room. This rapid internal mixing had an unexpected protective effect.

The Breath Plume Problem

When an infected person exhales, they release a concentrated cloud of respiratory particles. If you're standing face-to-face with them, you might inhale a significant dose of virus from that plume before it disperses.

Rapid air mixing breaks up these plumes almost instantly. The virus still ends up in the room air, but at much lower concentrations spread evenly throughout the space. Instead of inhaling a concentrated "hit," you're exposed to a diluted background level.

The Ventilation Paradox

This creates an interesting paradox for building design:

High fresh air ventilation: Removes viral particles from the room entirely. Good for reducing overall concentration.

High air recirculation: Dilutes concentrated breath plumes before they can be inhaled. Good for reducing short-range exposure.

Low ventilation + low mixing: The worst case. Viral plumes persist and concentrate in certain areas.

The researchers suggest future transmission studies should use facilities with "controlled, minimal air movement" to preserve the natural dynamics of exhaled breath plumes. In other words, the very features that made this experiment safe also made it impossible to observe transmission.


What Are the Practical Takeaways?

So what does this mean for you the next time someone sneezes in your office?

1. Proximity Isn't Destiny

Simply being in the same room with someone who has the flu doesn't guarantee you'll catch it. Transmission depends on multiple factors working together: how much virus they're shedding, your immune status, air circulation, and more.

2. Coughing and Sneezing Are the Main Spreaders

A person with mild flu symptoms who doesn't cough much may pose relatively low transmission risk. The classic "hacking cough" releases far more virus than quiet breathing or talking.

3. Your Immune History Matters

If you've had the flu before or received vaccinations over the years, your body has likely developed some degree of cross-reactive immunity. You're not defenseless, even against new strains.

4. Ventilation Helps—But It's Complicated

Good air circulation can reduce your risk, but the type of ventilation matters. Rapid air mixing dilutes viral plumes; fresh air exchange removes particles entirely. Both have protective effects, though they work differently.

5. Mild Seasons May Mean Milder Cases

The 2023–24 flu season was relatively mild. Cases recruited during mild seasons may shed less virus overall. The researchers noted that most of their donors were found through free testing kiosks rather than visiting health centers—suggesting milder illness.

📌 Key Takeaways at a Glance

  • Zero transmissions occurred despite 82+ hours of close contact
  • Coughing frequency strongly predicts viral shedding
  • Middle-aged adults showed stronger baseline immunity than younger donors
  • Air recirculation diluted viral plumes before recipients could inhale concentrated doses
  • Mild cases may be far less contagious than we assumed

What Questions Remain?

This study opened as many questions as it answered. The researchers themselves identified several limitations:

  • The flu season timing was unpredictable, making donor recruitment difficult
  • The rapid air mixing may have inadvertently prevented the transmission they were trying to observe
  • Mucosal immunity (protection in the nose and throat) wasn't examined
  • The sample size was small—just 5 donors and 11 recipients

Future studies will need to recruit donors who cough more frequently, use younger recipients with less accumulated immunity, and design environments that preserve natural breath plume dynamics.


A Note About Uncertainty

We want to be honest with you. One study—even a well-designed one—doesn't overturn everything we know about flu transmission. The findings are intriguing, but they come with caveats.

The lack of transmission could reflect unique circumstances: a mild flu season, donors who happened to shed little virus, recipients who happened to have strong immunity, and room conditions that happened to dilute viral plumes effectively.

Real-world transmission is messier. Crowded households, schools, and workplaces don't always have high-speed air mixing. Not everyone has decades of immune training. Some people cough a lot when they're sick.

What this study does tell us is that influenza transmission isn't as simple as "sick person in room = everyone gets sick." The picture is far more nuanced than that.


Conclusion

We started with a question: why didn't anyone catch the flu? The answer involves a perfect storm of low viral shedding, accumulated immunity, and air dynamics that dispersed viral plumes before they could cause infection.

This research reminds us that biology is never simple. Our assumptions about disease transmission—formed over lifetimes of "common knowledge"—don't always hold up under scientific scrutiny. And that's exactly why we keep asking questions.

At FreeAstroScience.com, we believe the sleep of reason breeds monsters. Stay curious. Keep questioning. Never stop learning.

Come back soon for more deep dives into the science that shapes our world. We'll be here, turning complex research into knowledge you can actually use.


Sources

  1. Lai J, Sobhani H, Coleman KK, et al. (2026) Evaluating modes of influenza transmission (EMIT-2): Insights from lack of transmission in a controlled transmission trial with naturally infected donors. PLOS Pathogens 22(1): e1013153. https://doi.org/10.1371/journal.ppat.1013153

  2. Intini E. (2026) Virus dell'influenza: per trasmetterlo non basta condividere la stanza. Focus.it. Published January 27, 2026.

  3. World Health Organization. (2024) Global technical consultation report on proposed terminology for pathogens that transmit through the air. WHO Publications.

  4. Yan J, Grantham M, Pantelic J, et al. (2018) Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community. Proceedings of the National Academy of Sciences 115(5):1081–1086.

  5. Cowling BJ, Ip DKM, Fang VJ, et al. (2013) Aerosol transmission is an important mode of influenza A virus spread. Nature Communications 4:1935.



Post a Comment

Previous Post Next Post